OMB APPROVAL
OMB Number 3235-0145
Expires: October 31, 1994
Estimated average burden
hours per response . .14.90
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13D
Under the Securities Exchange Act of 1934
(Amendment No. 2)*
APPLIED BIOMETRICS, INC.
(Name of Issuer)
Common Stock, $.01 par value
(Title of Class of Securities)
03814L103
(CUSIP Number)
William D. Corneliuson
777 East Wisconsin Avenue, Suite 3020, Milwaukee, Wisconsin 53202,
(414) 291-7400
(Name, Address and Telephone Number of Person Authorized to
Receive Notices and Communications)
February 20, 1997
(Date of Event which Requires Filing of this Statement)
If the filing person has previously filed a statement on Schedule 13G to
report the acquisition which is the subject of this Schedule 13D, and is
filing this schedule because of Rule 13d-1(b)(3) or (4), check the
following box [_].
Check the following box if a fee is being paid with the statement [_].
(A fee is not required only if the reporting person: (1) has a previous
statement on file reporting beneficial ownership of more than five percent
of the class of securities described in Item 1; and (2) has filed no
amendment subsequent thereto reporting beneficial ownership of five
percent or less of such class.) (See Rule 13d-7.)
Note: Six copies of this statement, including all exhibits, should be
filed with the Commission. See Rule 13d-1(a) for other parties to whom
copies are to be sent.
* The remainder of this cover page shall be filled out for a reporting
person's initial filing on this form with respect to the subject class of
securities, and for any subsequent amendment containing information which
would alter disclosures provided in a prior cover page.
The information required on the remainder of this cover page shall not be
deemed to be "filed" for the purpose of Section 18 of the Securities
Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of
that Section of the Act but shall be subject to all other provisions of
the Act (however, see the Notes).
<PAGE>
CUSIP No. 03814L103
1 NAME OF REPORTING PERSON
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
William D. Corneliuson - ###-##-####
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a) [_]
(b) [_]
N/A
3 SEC USE ONLY
4 SOURCE OF FUNDS*
N/A
5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT
TO ITEMS 2(d) OR 2(e) [_]
6 CITIZENSHIP OR PLACE OF ORGANIZATION
United States
7 SOLE VOTING POWER
NUMBER OF
192,767
SHARES
8 SHARED VOTING POWER
BENEFICIALLY
0
OWNED BY
9 SOLE DISPOSITIVE POWER
EACH
192,767
REPORTING
PERSON 10 SHARED DISPOSITIVE POWER
WITH 0
11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
192,767
12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN
SHARES* [_]
N/A
13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
4.6%
14 TYPE OF REPORTING PERSON*
IN
*SEE INSTRUCTIONS BEFORE FILLING OUT!
<PAGE>
Item 1. Security and Issuer
The title of the class of equity securities to which this
statement relates is Common Stock, par value $.01 per share (the "Common
Stock").
The name and address of the principal executive offices of the
issuer of the Common Stock is Applied Biometrics, Inc. (the "Company"),
501 East Highway 13, Suite 108, Burnsville, Minnesota 55337.
Item 2. Identity and Background
The following information is provided for each person:
(a) Name. William D. Corneliuson.
(b) Address. 777 East Wisconsin Avenue, Suite 3020,
Milwaukee, Wisconsin 53202.
(c) Principal Occupation and Employment. William D.
Corneliuson is President and Treasurer of B.C. Holdings, Inc.,
an investment advisory and consulting firm.
(d) Criminal Proceedings. None.
(e) Civil Proceedings. None.
(f) Citizenship. United States.
Item 3. Source and Amount of Funds or other consideration
Not Applicable.
Item 4. Purpose of Transaction
All of the reported shares are held for investment purposes.
The reporting person has no plans or proposals which relate to
or would result in:
(a) The acquisition by any person of additional securities
of the Company, or the disposition of securities of the Company;
(b) An extraordinary corporate transaction, such as a
merger, organization or liquidation, involving the Company or
any of its subsidiaries;
(c) A sale or transfer of a material amount of assets of
the Company or any of its subsidiaries;
(d) Any change in the present board of directors or
management of the Company, including any plans or proposals to
change the number or term of directors or to fill any existing
vacancies on the board;
(e) Any material change in the present capitalization or
dividend policy of the Company;
(f) Any other material change in the Company's business or
corporate structure including but not limited to, if the Company
is a registered closed-end investment company, any plans or
proposals to make any changes in its investment policy for which
a vote is required by section 13 of the Investment Company Act
of 1940;
(g) Changes in the Company's charter, bylaws or
instruments corresponding thereto or other actions which may
impede the acquisition of control of the Company by any person;
(h) Causing a class of securities of the Company to be
delisted from a national securities exchange or to cease to be
authorized to be quoted in an inter-dealer quotation system of a
registered national securities association;
(i) A class of equity securities of the Company becoming
eligible for termination of registration pursuant to
Section 12(g)(4) of the Act; or
(j) Any action similar to any of those enumerated above.
Item 5. Interest in Securities of the Issuer
(a) Number of Shares/Percentage of Class Beneficially Owned.
William D. Corneliuson beneficially owns a total of 192,767 shares of the
Company's Common Stock representing approximately 4.6% of the outstanding
shares of Common Stock based on 4,168,987 shares of Common Stock
outstanding as indicated by the Company as of November 4, 1996.
(b) Nature of Ownership. Mr. Corneliuson has sole power to
vote and direct the disposition of all of the reported shares.
(c) Recent Transactions. The following is a list of all
transactions in the Company's Common Stock by William D. Corneliuson
during the 60 days preceding the date of this Schedule 13D Amendment.
The shares below were sold through the NASDAQ small cap market
system:
Date of
Transaction Number of Shares Price Per Unit
01/30/97 27,000 $13.465
02/14/97 10,000 11.25
02/20/97 47,700 9.25
(d) Rights to Dividends or Proceeds. None.
(e) Not applicable.
Item 6. Contracts, Arrangements, Understandings or Relationships with
Respect to Securities of Issuer
None.
Item 7. Materials to be Filed as Exhibits
None.
<PAGE>
SIGNATURE
After reasonable inquiry and to the best of my knowledge and
belief, I certify that the information set forth in this statement is
true, complete and correct.
February 27, 1997 /s/ William D. Corneliuson
Date Signature
William D. Corneliuson
Name/Title
